申请人:Arrowhead Center, Inc.
公开号:US08349899B1
公开(公告)日:2013-01-08
Embodiments of the present invention comprises a compound of formula I or its enantiomer, diastereomer, stereoisomer or its pharmaceutically acceptable salt, methods of use and methods of synthesis.
本发明实施例包括公式I的化合物或其对映体、非对映体、立体异构体或其药学上可接受的盐,使用方法和合成方法。